AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $738,963 | -1.2% | 60,770 | +2.0% | 0.01% | 0.0% |
| Q2 2023 | $748,036 | +10.5% | 59,557 | -2.5% | 0.01% | 0.0% |
| Q1 2023 | $677,089 | -6.6% | 61,054 | +2.9% | 0.01% | -14.3% |
| Q4 2022 | $724,810 | +21.6% | 59,362 | +4.0% | 0.01% | +16.7% |
| Q3 2022 | $596,000 | -2.5% | 57,100 | +0.3% | 0.01% | 0.0% |
| Q2 2022 | $611,000 | +7.0% | 56,916 | -5.5% | 0.01% | +20.0% |
| Q1 2022 | $571,000 | -13.9% | 60,256 | +5.0% | 0.01% | 0.0% |
| Q4 2021 | $663,000 | +19.7% | 57,394 | -1.0% | 0.01% | 0.0% |
| Q3 2021 | $554,000 | 0.0% | 57,978 | +0.9% | 0.01% | 0.0% |
| Q2 2021 | $554,000 | -17.9% | 57,479 | -15.8% | 0.01% | -16.7% |
| Q1 2021 | $675,000 | -56.7% | 68,272 | +1.1% | 0.01% | -57.1% |
| Q4 2020 | $1,560,000 | +57.9% | 67,544 | -3.5% | 0.01% | +40.0% |
| Q3 2020 | $988,000 | +14.0% | 69,971 | +21.7% | 0.01% | -16.7% |
| Q2 2020 | $867,000 | +56.8% | 57,512 | -3.9% | 0.01% | +20.0% |
| Q1 2020 | $553,000 | – | 59,820 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |